CPhI & P-MEC India expo to encourage cost-effective solutions in India’s march towards Rs 10.5 lakh crore pharma market by 2030

The Indian pharma industry is set to grow at a 12 per cent CAGR and reach $130billion (Rs 10.5 lakh crores) by 2030. The show will be a part of the India Pharma Week, catering to every need of the pharma community attendees. To stimulate the anticipated growth of the industry, a pre-connect congress will take place on 28th November, 2022 at Crowne Plaza, Mayur Vihar, New Delhi, a statement from Informa Markets has notified. .

The 15th edition of CPhI and P-Mec India will be held from 29th November to 1st December, 2022 at the India Expo Centre, Greater Noida. The show creates platforms to showcase modern technologies critical in facilitating advancement in India’s pharma machinery, technology and ingredients industries, the statement added.

Emphasising on this year’s CPhI & P-MEC India Expo, Yogesh Mudras, Managing Director, Informa Markets, India, said in the statement, “The Indian pharma market is rising at an annual growth rate of 15 per cent, which is twice the world market growth rate. To further accelerate the growth of this industry, the government has approved incentives to the tune of almost Rs 22,000 crore and 100 per cent FDI, under the automatic route for greenfield pharma.

“Over the last 15 years, our show CPhI and P-MEC India has demonstrated excellence in supporting the industry and growing along with it by curating highly effective platforms for showcasing technology solutions, knowledge sharing, networking and advocacy in the past, and will continue to act as a catalyst to ‘Make in India’ movement and provide an impetus to Indian economy. The expo will surely provide a huge platform to establish and enhance business by meeting active suppliers looking for collaboration with the Indian pharma and healthcare market. Every edition of CPhI and P-MEC India has set a successful milestone for its esteemed visitors, and, this year too, we will raise the bar to give a significant boost to this industry.”

According to the statememt, the show starts with the pre-connect Congress that will include Amit Saluja, Senior Director and Centre Head, Gandhinagar CoE, NASSCOM, Gandhinagar; Dr Sanjit Singh Lamba, CEO, Biocuris; Suresh Pattathil, President – OPPI, and Managing Director and General Manager, Allergan India; and Vikram Srivastava, Head, Global Supply chain, Sun Pharma, among others. The key topics of the panel discussions would include ‘Disrupting the pharmaceutical industry in the age of rapid technological growth’, ‘Paving the pathway for innovation in pharma R&D’,’ Adaptive, responsive, and flexible supply chain to fuel pharma growth’ and ‘Changing global dynamics and opportunities for enhancing India’s pharma exports.’

Alongside the display of the latest technologies of CPhI & P-MEC India, the India Pharma Week will include 9th Annual India pharma awards and CEO Roundtable on Day one that will bring all key stakeholders in the pharma industry on a single platform to discuss, deliberate and share their thoughts on achieving the next phase of growth in pharma. Day two will see women in pharma roundtable, an initiative aimed at acknowledging and celebrating the significant and continued contribution of women to the pharma industry in a closed-door roundtable discussion, notified the statement.

The expo will yet again be a marketplace to bridge the ecosystem with knowledge, technologies and market opportunities. CPhI & P-MEC India are expected to witness more than 1,500 exhibitors, more than 40,000 visitors and representation from over 80 countries over the three days. It gives direct access to highly targetted senior pharma executives, buyers, procurement managers, contract manufacturers, hospital administration, and many more along with national and state regulatory boards, and policymakers to congregate and conduct business, arrive at solution-driven innovations to counteract economic uncertainties and domestic trade in India.